Drug Type Small molecule drug |
Synonyms IMDZQ, 3M-852A, 852A + [2] |
Target |
Mechanism TLR7 agonists(Toll like receptor 7 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H23N5O2S |
InChIKeyYZOQZEXYFLXNKA-UHFFFAOYSA-N |
CAS Registry532959-63-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 2 | US | 01 Apr 2006 | |
Endometrial Carcinoma | Phase 2 | US | 01 Apr 2006 | |
Ovarian Cancer | Phase 2 | US | 01 Apr 2006 | |
Uterine Cervical Cancer | Phase 2 | US | 01 Apr 2006 | |
Acute Lymphoblastic Leukemia | Phase 2 | US | 01 Jan 2006 | |
Acute Myeloid Leukemia | Phase 2 | US | 01 Jan 2006 | |
Chronic Lymphocytic Leukemia | Phase 2 | US | 01 Jan 2006 | |
Hodgkin's Lymphoma | Phase 2 | US | 01 Jan 2006 | |
Multiple Myeloma | Phase 2 | US | 01 Jan 2006 | |
Melanoma, Cutaneous Malignant | Phase 2 | FR | 01 Feb 2005 |
Phase 2 | 6 | defwweuamf(cyickacnbr) = uucxurreag jcihfcohbh (rhmyxpxczo, vhdwesmtvj - ipzqwxtirn) View more | - | 05 May 2010 | |||
Phase 2 | 15 | (Patients With Ovarian Cancer) | srclaanqnv(owffkblcrh) = bwvvaafjih myoamtgeiv (jdxzgmwtxy, vtxuhrlbud - snxbmmugzq) View more | - | 25 Sep 2009 | ||
(Patients Treated With 852A) | gjbmnvaxpd(prhciuhnbq) = aiavufokio dnumfrxdkn (qcomjsupvh, remzuxayyn - rrrwzobqdp) View more |